Company news
Eden Research plc news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Approval of MevaloneT in Portugal
September 25, 2017
Completion of Placing & Subscription
June 30, 2017
New terms agreed with UMMS
June 29, 2017
Final Results
May 22, 2017
Eden Research on BBC Radio 4's You & Yours
May 11, 2017
Extension of patent protection in Greece
March 29, 2017
Voting Rights, Warrants and Options Outstanding
March 8, 2017
Fungicide product approved for sale in France
January 23, 2017
Trading update
December 21, 2016
Label extensions for 3AEY in Spain and Greece
June 15, 2016
Placing to raise £2.6m
March 30, 2016
Approval of 3AEY in Spain
February 22, 2016
Approval of 3AEY in Italy
February 11, 2016
First shipment of MevaloneT (3AEY) to Greece
February 10, 2016
Exercise of options
January 21, 2016
Further progress with EU product approvals
January 14, 2016
Kenya approval & first commercial-scale order
November 16, 2015
Appointment of Nominated Adviser and Broker
October 26, 2015
Collaboration and Licence Agreement Signed
September 24, 2015
Product approval in Greece
September 1, 2015
TerpeneTech Licence Agreement and Investment
August 24, 2015
Active substances approved for MRL exemption
June 25, 2015
EU Product Authorisation
May 26, 2015
Agreement with Sipcam covering new products
May 20, 2015
Appointment of a Director and Share Options
May 11, 2015
Option agreement with Taminco
April 13, 2015
Death of a Director
February 18, 2015
Grant of Patent in South Korea
February 2, 2015
Directorate Change
January 8, 2015
Progress on EU zone approval
December 19, 2014
Licence Agreement with SUMIAGRO
December 1, 2014
Conversion of all outstanding debt
November 28, 2014
Placing to raise?750,000
November 21, 2014
Successful trials in Greece to combat Botrytis
September 29, 2014
Norwegian Patent Granted
September 26, 2014
Directorate changes & share options
August 18, 2014
Evaluation agreement for nematicide
August 11, 2014
Notice of Decision of Patent in South Korea
July 1, 2014
Extension of TerpeneTech licence agreement
June 6, 2014
Preliminary Results
May 30, 2014
Notice of Allowance for Mexican patent
May 15, 2014
Notice of Allowance for Canada patent
April 24, 2014
First commercial products launched with Eden tech
April 22, 2014
Further progress in EU product approval
March 10, 2014
Data Access Licence and Royalty Agreement
January 13, 2014
Notice of Allowance from ARIPO
October 9, 2013
Notice of Allowance
August 28, 2013
Licence agreement for head lice treatment
June 5, 2013
EU approval for active substances
May 20, 2013
Master Encapsulation Patent Granted in Europe
March 15, 2013
Calls
The 5 newest of 7 calls. Every call is listed under its year.
- Eden Research (LSE:EDEN) — Preliminary results for the fifteen months ended 31 March 2026
Aug 26, 2026
Transcript - Eden Research (LSE:EDEN) — Interim Results
Sep 17, 2025
Transcript - Eden Research (LSE:EDEN) — Preliminary results for the year ended 31 December 2024
May 14, 2025
Transcript - Eden Research (LSE:EDEN) — Investor Update - February 2025
Feb 13, 2025
Transcript - Eden Research (LSE:EDEN) — Interim Results
Sep 23, 2024
Transcript
Decks
The 5 newest of 21 decks. Every deck is listed under its year.
- Shareholder Meeting (September 2026)
Shareholder meeting · 27 slides · Sep 29, 2026
- 15 months to 31 March 2026 Earnings Presentation
Earnings · 25 slides · August 2026
- H1 2025 Earnings Presentation
Earnings · 19 slides · Sep 17, 2025
- Shareholder Meeting (June 2025)
Shareholder meeting · 16 slides · Jun 18, 2025
- FY2024 Earnings Presentation
Earnings · 15 slides · May 2025